首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
admin
2013-11-29
118
问题
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolution is based on the idea that the sicker people are, the more freedom they should have to try drugs that are not yet fully tested. For fifty years government policy has been driven by another idea: the fear that insufficiently tested medicines could cause deaths and injuries. The urgent needs of people infected with HIV, the AIDS virus, and the possibility of meeting them with new drugs have created a compelling countervailing force to the continuing concern with safety. As a result, government rules and practices have begun to change. Each step is controversial. But the shift has already gone far beyond AIDS. New ways are emerging for very sick people to try some experimental drugs before they are marketed. People with the most serious forms of heart disease, cancer, emphysema, Alzheimer’ s or Parkinson’ s disease, multiple sclerosis, epilepsy, diabetes, or other grave illnesses can request such drugs through their doctors and are likelier to get them than they would have been four years ago. "We’ve been too rigid in not making lifesaving drugs available to people who otherwise face certain death," says Representative Henry Waxman, of California, who heads the subcommittee that considers changes in drug-approval policies. "It’s true of AIDS, but it’s also true of cancer and other life- threatening diseases."
For the first time, desperate patients have become a potent political force for making new medicines available quickly. People with AIDS and their advocates, younger and angrier than most heart-disease or cancer patients, are drawing on two decades of gay activists’ success in organizing to get what they want from politicians. At times they found themselves allied with Reagan Administration deregulators, scientists, industry representatives, FDA staff members, and sympathetic members of Congress. They organized their own clinical trials and searched out promising drugs here and abroad. The result is a familiar Washington story: a crisis—AIDS—helped crystallize an informal coalition for reform.
AIDS gave new power to old complaints. As early as the 1970s the drug industry and some independent authorities worried that the Food and Do, g Administration’ s testing requirements were so demanding that new drugs were being unreasonably delayed. Beginning in 1972, several studies indicated that the United States had lost its lead in marketing new medicines and that breakthrough drugs—those that show new promise in treating serious or life-threatening diseases— had come to be available much sooner in other countries. Two high-level commissions urged the early release of breakthrough drugs. So did the Carter Administration, but the legislation it pro- posed died in Congress. Complaints were compounded by growing concern that "if we didn’t streamline policies, red tape wot, Id be an obstacle to the development of the biotechnology revolution," as Frank E. Young, who was the head of the FDA from 1984 to 1989, put it in an interview with me.
Young was a key figure in the overhaul of the FDA’s policies. A pioneer in biotechnology and a former dean of the University of Rochester’s medical school, he came to Washington with an agenda and headed the agency for five and a half years—longer than anyone else has since the 1960s. Young took the FDA job to help introduce new medicines created by biotechnology-- whose promise he had seen in his own gene-cloning lab--and to get experimental medicines to desperately iii people more quickly. He had seen people die waiting for new medicines because "they were in the wrong place at the wrong time," he said. That is now changing.
From the second paragraph, we learn that ______.
选项
A、AIDS people tend to get angrier than all cancer patients
B、AIDS people have learned some experience from homosexual people in dealing with politicians
C、AIDS people have got some representatives in government organizations
D、AIDS people often work together with gay activists
答案
B
解析
转载请注明原文地址:https://kaotiyun.com/show/vHhO777K
0
考博英语
相关试题推荐
AmericaLosesaGreatPublicThinkerArthurMiller’sdeathlastweekmeantmorethanthelossofanoutstandingplaywright.
Islanguage,likefood,abasichumanneedwithoutwhichachildatacriticalperiodoflifecanbestarvedanddamaged?Judgin
TheearlyretirementofexperiencedworkersisseriouslyharmingtheUSeconomy,accordingtoanewreportfromtheHudsonInsti
Youheartherefrainallthetime:theU.S.economylooksgoodstatistically,butitdoesn’tfedgood.Whydoesn’tever-greater
Although"namingrights"haveproliferatedinAmericanhighereducationforthepastseveraldecades,thephenomenonhasrecentl
Theincreaseinglobaltrademeansthatinternationalcompaniescannotaffordtomakecostlyadvertisingmistakesiftheywantt
Justiceinsocietymustincludebothafairtrialtotheaccusedandtheselectionofanappropriatepunishmentforthoseproven
Itis3A.M.everythingontheuniversitycampusseemsghostlikeinthequiet,mistydarkness-everythingexceptthecomputerce
Thedramacritic,ontheotherhand,hasnosuchadvantage.Hecannotbeselective;hemustcovereverythingthatisofferedfor
56.Realestate,inbroaddefinition,islandandeverythingmadepermanentlyapartthereof,andthenatureandextentofone’s
随机试题
在美国,________政策与地方政策之间存在着决定与被决定、服从与被服从的关系。()
20世纪60年代,率先将商业秘密视为知识产权的组织为()
PowerPoint2010中,对插入的图片进行裁剪后不能再恢复原状。
Thedifferencebetweenlifeinonecountryandthatinanotherisquiteoftennotsobigasthedifferencebetweencitylifeand
下列关于项目目标动态控制的表述中,正确的有()。
在我国,应付票据无论是否带息,都按照票据面值计算。()
旅游的基本特征包括()。
我国遏制和惩戒违反公平交易原则行为的法规有()。
下列说法中,不属于学前儿童语言教育活动评价主要目标的是()。
中国有4000多年的历史,是世界最古老的文明之一。从公元前21世纪的夏朝开始至清朝结束,中国历史上经历过几十个朝代的变更。每个朝代在政治、经济、文化、科技领域等都有独特的成就。汉朝是当时世界上最先进的帝国,“汉族”(theHanNationality)
最新回复
(
0
)